课题基金 / 基金详情

In vivo Analysis of RORgamma mediated Functions

In vivo Analysis of RORgamma mediated Functions
RORgamma 介导功能的体内分析
批准号:
6824560
负责人:
Zuoming Sun
金额:
$33.93万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-06-01 至 2009-05-31

项目摘要

项目成果

Zuoming Sun的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Apoptosis is an essential physiological process required for the development and maintenance of homeostasis in an organism. The Bcl-2 proto-oncogene is a critical regulator of the apoptotic signaling pathways. Altered expression of Bcl-2 contributes to cancer pathogenesis and resistance to chemotherapeutic drugs due to failed induction of apoptosis. Apoptosis serves to eliminate majority of the developing thymocytes that are either not recognized by major histocompatibility complexes or self-reactive. By gene targeting, we have demonstrated that retinoid-related orphan receptor gamma (RORgamma), a member of the nuclear receptor family, plays a critical role in the development of thymocytes and lymph nodes. In the absence of RORgamma, thymocytes undergo rapid apoptosis and unregulated entry into S phase of the cell cycle. Correspondingly, RORgamma deficient thymocytes have significant lower levels of anti-apoptotic Bcl-xL and cell cycle inhibitor p27kip1. Overexpression of Bcl-xL in the RORgamma deficient thymocytes restores survival and cell cycle progression. RORgamma null mice fail to develop lymph nodes, likely due to absence of lymph node progenitors in the early embryonic stages. We hypothesize that RORgamma regulates expression of the critical survival and cell cycle molecules that are required for the development of thymocytes and lymph nodes. We propose to study the molecular mechanisms responsible for RORgamma mediated transcription and its function in thymocyte maturation in vivo. In addition, we will examine how RORgamma regulates the development of peripheral lymphoid organs. The proposed studies will gain insight into nuclear receptor regulated functions in development of T cells and the secondary lymphoid tissues in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Function of TCF-1 in antagonizing malignancy
Function of TCF-1 in antagonizing malignancy
Differential mechanisms for RORgammat-regulated thymocyte development and Th17 di
Differential mechanisms for RORgammat-regulated thymocyte development and Th17 di
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
  • 批准号:
    31970691
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    张胜萍
  • 依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
  • 批准号:
    31900527
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2019
  • 负责人:
    孙磊
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位: